TNF-alpha(TNF-α) is a 17-kDa protein consisting of 157 amino acids that is a homotrimer in solution. In humans, the gene is mapped to chromosome 6. Its bioactivity is mainly regulated by soluble TNF-α–binding receptors. TNF-α is mainly produced by activated macrophages, T lymphocytes, and natural killer cells. Lower expression is known for a variety of other cells, including fibroblasts, smooth muscle cells, and tumor cells. In cells, TNF-α is synthesized as pro-TNF (26 kDa), which is membrane-bound and is released upon cleavage of its pro domain by TNF-converting enzyme (TACE).
Cat. No. | Product Name | CAS No. | Information |
---|---|---|---|
H1754 |
UTL-5g |
646530-37-2 | UTL-5g (GBL-5g) is a novel potential chemoprotective agent, TNF-α inhibitor that reduces cisplatin-induced side effects including nephrotoxicity, hepatotoxicity and hematotoxicity; lowers elevated levels of AST, ALT, creatinine, BUN, and TNF-α, increases the reduced platelet count in mice; a novel chemo- and radioprotective agent. |
H1753 |
TNFα-IN-C87 |
332420-90-3 | A novel and highly specific small-molecule TNFα inhibitor that directly binds to TNFα, potently inhibits TNFα-induced cell death (IC50=8.73 uM) and effectively blocks TNFα-triggered signaling activities; effectively attenuates TNFα-induced inflammation in a murine acute hepatitis model. |
H1752 |
SPD-304 |
869998-49-2 |
SPD-304 is an inhibitor of tumor necrosis factor α (TNFα) that prevents binding to the TNF Receptor 1 (TNFR1) with IC50 of 22 uM; binds to the biologically active TNFα trimer and promotes accelerated displacement of a single subunit to rapidly inactivate the cytokine; inhibits TNFα-mediated stimulation of IKB degradation with an IC50 of 4.6 uM in a cell based assay. |
H1751 |
Pomalidomide |
19171-19-8 | A potent inhibitor of TNF-α production; inhibits LPS-induced TNF-α release with IC50 of 13 nM in PBMCs; upregulates interferon gamma, IL-2 and IL-10. |
H1750 |
Mitochonic Acid 35 |
1611470-23-5 | A dual inhibitor of TNF-α and TGF-β1 by inhibiting IκB kinase phosphorylation and Smad3 phosphorylation; attenuates the LPS/GaIN-induced hepatic inflammation in the mice, and downregulates TGF-β1-induced fibrotic gene expression; attenuates renal inflammation and fibrosis with the downregulation of inflammatory cytokines and fibrotic gene expressions in renal fibrosis model. |
H1749 |
LMP-420 |
473870-63-2 | A small-molecule, orally active inhibitor of TNF-α that reduces replication of HIV-1 (IC50=300 nM) and Mycobacterium tuberculosis in human cells; also shows potent cytotoxic effects for CLL cells (ED50=245 nM, 72h) and minimal toxicity for normal hematopoietic cells; decreases colonic TNF levels in IL-10-deficient mice with chronic colitis. |
H1748 |
JNJ525 |
2092913-64-7 | JNJ525 is a small molecule inhibitor of TNFα that prevents the formation of TNFα complexes with TNFR1 and TNFR2 with IC50 of 1.2 uM and 1.1 uM in the TR-FRET assay, respectively. |
H1747 |
IW-927 |
389142-48-7 | A potent TNFα/TNFRc1 interaction antagonist with IC50 of 50 nM, with no affinity for the related cytokine receptors TNFRc2 or CD40, and no cytotoxicity (>100 uM); also blocks TNF-stimulated phosphorylation of Ikappa-B in Ramos cells (IC50=600 nM) |
086-18516630705
sales@hmobio.com
1/F, building 4, No. 358-368, Kefu Road, Jiading District, Shanghai, China